Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001415889-24-007863

CHIEF FINANCIAL OFFICER gave up 1,912 shares (to pay taxes)

  • CHIEF FINANCIAL OFFICER acquired 4,908 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jeanmonod Patrik CHIEF FINANCIAL OFFICER 2024-03-11 Option exercise +4,908 99,377 D
Jeanmonod Patrik CHIEF FINANCIAL OFFICER 2024-03-11 Shares withheld for taxes −1,912 $7.22 $13,805 97,465 D
Derivatives
Jeanmonod Patrik CHIEF FINANCIAL OFFICER 2024-03-11 Option exercise · Restricted Stock Units −4,908 44,182 D
Loading xslF345X05/form4-03132024_100341.xml…